Literature DB >> 563332

Enkephalin: radioimmunoassay and radioreceptor assay in morphine dependent rats.

S R Childers, R Simantov, S H Snyder.   

Abstract

A sensitive and specific radioimmunoassay for enkephalins is described which discriminates between leucineenkephalin and methionine-enkephalin. Total opioid peptide activity was assayed by the ability of brain extracts to compete for opiate receptor binding. In rats treated with morphine and/or naloxone, opiates were separated from opioid peptides by Dowex AG-50W column chromatography prior to radioreceptor assay. Chronic administration of morphine failed to alter immunoreactive enkephalin levels or total opioid activity in radioreceptor assays.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 563332     DOI: 10.1016/0014-2999(77)90346-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Decreases in endogenous opioid peptides in the rat medullo-coerulear pathway after chronic morphine treatment.

Authors:  E J Van Bockstaele; J Peoples; A S Menko; K McHugh; G Drolet
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

Review 2.  Enkephalins and Endorphins. Clinical, pharmacological and therapeutic implications.

Authors:  D L Copolov; R D Helme
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

Review 3.  Neuroadaptive responses in brainstem noradrenergic nuclei following chronic morphine exposure.

Authors:  E J Van Bockstaele; A S Menko; G Drolet
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

4.  Opiates induce long-term increases in prodynorphin-derived peptide levels in the guinea-pig myenteric plexus.

Authors:  R Schulz; K Metzner; T Dandekar; C Gramsch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

5.  The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.

Authors:  I Nylander; M Vlaskovska; L Terenius
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.